A randomised phase 2 trial of intensive induction chemotherapy (CBOP/BEP) and standard BEP in poor-prognosis germ cell tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604).

Advanced search
Browse by:

Department | Year

UCL Theses | Latest

Deposit your research

A randomised phase 2 trial of intensive induction chemotherapy (CBOP/BEP) and standard BEP in poor-prognosis germ cell tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604).

Huddart, RA; Gabe, R; Cafferty, FH; Pollock, P; White, JD; Shamash, J; Cullen, MH; ... National Cancer Research Institute Testis Cancer Clinical Studies Group, .; + view all (2015) A randomised phase 2 trial of intensive induction chemotherapy (CBOP/BEP) and standard BEP in poor-prognosis germ cell tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604). Eur Urol , 67 (3) 534 - 543. 10.1016/j.eururo.2014.06.034. Green open access

[thumbnail of 1-s2.0-S0302283814006083-main.pdf]

PDF
1-s2.0-S0302283814006083-main.pdf
Download (1MB)

Abstract

Standard chemotherapy for poor-prognosis metastatic nonseminoma has remained bleomycin, etoposide, and cisplatin (BEP) for many years; more effective regimens are required.

Type:	Article
Title:	A randomised phase 2 trial of intensive induction chemotherapy (CBOP/BEP) and standard BEP in poor-prognosis germ cell tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604).
Location:	Switzerland
Open access status:	An open access version is available from UCL Discovery
DOI:	10.1016/j.eururo.2014.06.034
Publisher version:	http://dx.doi.org/10.1016/j.eururo.2014.06.034
Language:	English
Additional information:	© 2015 The Authors. Published by Elsevier B.V. on behalf of European Association of Urology. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Keywords:	Metastatic germ cell tumour, Poor prognosis, Randomised trial
UCL classification:	UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology
URI:	https://discovery.ucl.ac.uk/id/eprint/1435634